Charles W Newhall Iii sold $388K of Supernus Pharmaceuticals (SUPN)

Executed Nov 11 2024, disclosed Nov 12 2024, 1 day later.

Value, as filed

$388K

10,700 sh × $36.24

Executed

Nov 11 2024

the trade date, as filed

Disclosed

Nov 12 2024

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

CI Charles W Newhall Iii Director profile →

Charles W Newhall Iii (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in SUPN. The largest single filing was $1.2M of SUPN (23,800 sh × $50.73, as filed), executed Oct 9 2025.

The name

SUPN SUPN SUPN · 38 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Charles W Newhall Iii in SUPN

SUPNSALE SUPERNUS PHARMACEUTICALS, INC. $1.2M
23,800 sh × $50.73
Exec Oct 9 2025
Filed Oct 10 2025 · 5:30 PM ET SUPNSALE SUPERNUS PHARMACEUTICALS, INC. $161K
3,588 sh × $45.01
Exec Aug 27 2025
Filed Aug 29 2025 · 5:30 PM ET